Prediction Model of Leibovich et al for Patients with Clear Cell Renal Cell Carcinoma After Radical Nephrectomy

Purpose: To determine risk for metastatic disease in a patient with a clinically localized clear cell renal cell carcinoma using the model of Leibovich et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with a clinically localized renal cell carcinoma at the time of radical nephrectomy?

Yes

Is the tumor histologically of clear cell type?

Yes

Tumor diameter

Is tumor necrosis seen in the histologic sections?

Yes

Select an appropriate answer for each finding

Pathologic T stage

Pathologic lymph node stage

Nuclear grade

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total score

Risk for developing metastatic disease

Probability of 1 year metastasis free survival

Probability of 5 year metastasis free survival

Probability of 10 year metastasis free survival

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Clear Cell Renal Cell Carcinoma Prognostic Factors
- Chances of Aggressive Carcinoma in Renal Tumor Removed By Partial Nephrectomy
Clinical Diagnosis, Including Family History For Genetics
- Aggressive Phenotypic Features for Chromophobe Renal Cell Carcinoma
- Diagnostic Features of a Chromophobe Renal Cell Carcinoma
Severity, Prognosis, Stage

Monitoring

Response To Therapy
- The Stage, Size, Grade and Necrosis (SSIGN) Score of Frank et al for Predicting Survival in a Patient with a Clear Cell Renal Cell Carcinoma
Disease Progression
- Chances of Aggressive Carcinoma in Renal Tumor Removed By Partial Nephrectomy

Specialty

Hematology Oncology
Surgery, general
Nephrology

Objective

severity
prognosis
stage
response to therapy

ICD-10

C64 - Malignant neoplasm of kidney, except renal pelvis

Info

Purpose: To determine risk for metastatic disease in a patient with a clinically localized clear cell renal cell carcinoma using the model of Leibovich et al.

Specialty: Hematology Oncology, Surgery, general, Nephrology

Objective: severity, prognosis, stage, response to therapy

ICD-10: C64,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path